MLAB — Mesa Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual balance sheet for Mesa Laboratories, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2019 March 31st	R2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	10.2	81.4	264	49.3	32.9
Net Total Accounts Receivable
Net Total Receivables	12.5	21.1	23.8	41.2	42.6
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	33.6	123	304	124	119
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	22.2	24.5	23.8	38.8	36.8
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	157	409	601	707	662
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	23.7	26	32.6	48.1	43.4
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	45.5	189	195	314	268
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	111	220	406	394	393
Total Liabilities & Shareholders' Equity	157	409	601	707	662
Total Common Shares Outstanding